Supporting the designation of July 2020 as Uterine Fibroids Awareness Month.

IV 116TH CONGRESS 2D SESSION H. RES. 1040 Supporting the designation of July 2020 as Uterine Fibroids Awareness Month. IN THE HOUSE OF REPRESENTATIVES JULY 1, 2020 Mr. DAVID SCOTT of Georgia (for himself, Ms. CLARKE of New York, Ms. BLUNT ROCHESTER, Mr. CONNOLLY, Ms. MOORE, Mr. HURD of Texas, Ms. NORTON, Mrs. LAWRENCE, Mr. BUTTERFIELD, Mr. RUSH, Mr. GRI- JALVA, and Mr. VAN DREW) submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Supporting the designation of July 2020 as Uterine Fibroids Awareness Month. Whereas fibroids may cause significant morbidity through their presence in the uterus and pelvic cavity, causing significant pelvic pain, abnormal uterine bleeding, repro- ductive dysfunction, miscarriages, and even infertility; Whereas the pain, discomfort, stress, and other physical and emotional symptoms of living with fibroids may signifi- cantly interfere with a woman’s quality of life, compro- mising her ability to function normally, work, or care for her family, and may lead to more severe health and wellness issues; VerDate Sep 11 2014 03:51 Jul 02, 2020 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR1040.IH HR1040 pamtmann on DSKBC07HB2PROD with BILLS 2 •HRES 1040 IH Whereas uterine fibroids are the most prevalent medical con- dition affecting women, with an estimated 30 percent of women developing a uterine fibroid by age 35, and 80 percent of women developing a uterine fibroid by age 50; Whereas the exact number of affected women is unknown, as early detection and diagnosis are difficult because only 1 out of 4 women who have a uterine fibroid exhibit symp- toms severe enough to require treatment; Whereas the overall incidence of uterine fibroids is estimated to disproportionately impact Black and Hispanic women, who also experience more severe symptoms, resulting in an incidence rate that is 3 times greater in women with Black ancestry and 2 times greater in Hispanic women compared to Caucasian women; Whereas a hysterectomy, or removal of the uterus, is among the most common surgical treatments for uterine fibroids, and more than 200,000 hysterectomies are per- formed each year to treat uterine fibroids, at an esti- mated annual cost of more than $2,000,000,000; Whereas uterine fibroids were estimated to cost the United States $5,900,000,000 to $34,400,000,000 annually with an estimated annual lost work cost of $1,600,000,000 to $17,200,000,000 through absenteeism and short-term disability in women ages 25 to 54; and Whereas public awareness and education campaigns on uter- ine fibroids prevention, screening, and symptoms are held during the month of July each year: Now, therefore, be it Resolved, That the House of Representatives— 1 (1) supports the goals and ideals of Uterine 2 Fibroids Awareness Month; 3 VerDate Sep 11 2014 03:51 Jul 02, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\HR1040.IH HR1040 pamtmann on DSKBC07HB2PROD with BILLS 3 •HRES 1040 IH (2) recognizes the disparity in incidence rates 1 for Black and Hispanic uterine fibroid patients; 2 (3) recognizes the need for greater research, 3 treatment, and care options regarding uterine 4 leiomyoma; and 5 (4) encourages the President to issue a procla- 6 mation calling upon the people of the United States 7 to observe the month with appropriate awareness 8 and educational activities. 9 Æ VerDate Sep 11 2014 03:51 Jul 02, 2020 Jkt 099200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\HR1040.IH HR1040 pamtmann on DSKBC07HB2PROD with BILLS